The tumor ablation market size has grown rapidly in recent years. It will grow from $1.62 billion in 2025 to $1.81 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to growing incidence of solid tumors, increased adoption of minimally invasive cancer treatments, expansion of oncology care centers, availability of advanced imaging guidance, improved clinical outcomes of ablation therapies.
The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for targeted cancer therapies, rising investments in precision oncology solutions, expansion of outpatient cancer treatment facilities, integration of ai-based treatment planning, growing focus on patient-centric cancer care. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of image-guided ablation technologies, growing preference for thermal ablation techniques, expansion of outpatient tumor treatment settings, enhanced focus on precision oncology.
The rising adoption of minimally invasive procedures is expected to drive the growth of the tumor ablation market going forward. Minimally invasive interventions, including robot-assisted surgeries, involve surgical techniques that use small or no incisions to reduce recovery time, minimize complications, and lower postoperative pain. This trend is fueled by growing patient demand for faster recovery, advancements in surgical robotics, and improved imaging-guided treatment accuracy. Tumor ablation technologies - such as radiofrequency, microwave, and cryoablation - support this shift by enabling precise destruction of cancerous tissue while preserving surrounding healthy structures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing use of minimally invasive procedures is driving the growth of the tumor ablation market.
Major companies in the tumor ablation market are focusing on developing advanced solutions, such as bone tumor ablation systems, to improve treatment precision, enhance patient outcomes, and broaden the spectrum of treatable tumors. A bone tumor ablation system is a specialized device designed for minimally invasive treatment of bone tumors. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2 bone tumor ablation system. The upgraded system is intended for treating painful bone metastases and benign bone tumors, including osteoid osteoma. OsteoCool 2 allows simultaneous use of four internally cooled probes, enabling ablation of two vertebral bodies at once or creating larger ablation zones in extra-spinal applications. The system delivers 20W per channel, more than double the power of the Stryker OptaBlate bone tumor ablation system.
In August 2025, K5 Global, a US-based growth-focused technology investment firm, acquired HistoSonics Inc. for $2.25 billion. Through this acquisition, K5 Global aims to accelerate the global commercialization of HistoSonics’ non-invasive tumor-ablation platform and expand its clinical and regulatory presence. HistoSonics is a US-based healthcare technology company that develops the Edison histotripsy system, a focused-ultrasound solution for non-invasive soft-tissue tumor ablation.
Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech.
North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tumor ablation market by increasing costs of imported ablation probes, generators, imaging guidance systems, and precision electronic components. Oncology centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressures on export-oriented manufacturing. These tariffs are increasing procedural equipment costs and slowing technology adoption. However, they are also encouraging domestic device production, localized component sourcing, and innovation in cost-efficient ablation systems.
The tumor ablation market research report is one of a series of new reports that provides tumor ablation market statistics, including tumor ablation industry global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.
The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.
The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The tumor ablation market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for targeted cancer therapies, rising investments in precision oncology solutions, expansion of outpatient cancer treatment facilities, integration of ai-based treatment planning, growing focus on patient-centric cancer care. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of image-guided ablation technologies, growing preference for thermal ablation techniques, expansion of outpatient tumor treatment settings, enhanced focus on precision oncology.
The rising adoption of minimally invasive procedures is expected to drive the growth of the tumor ablation market going forward. Minimally invasive interventions, including robot-assisted surgeries, involve surgical techniques that use small or no incisions to reduce recovery time, minimize complications, and lower postoperative pain. This trend is fueled by growing patient demand for faster recovery, advancements in surgical robotics, and improved imaging-guided treatment accuracy. Tumor ablation technologies - such as radiofrequency, microwave, and cryoablation - support this shift by enabling precise destruction of cancerous tissue while preserving surrounding healthy structures. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022. Therefore, the increasing use of minimally invasive procedures is driving the growth of the tumor ablation market.
Major companies in the tumor ablation market are focusing on developing advanced solutions, such as bone tumor ablation systems, to improve treatment precision, enhance patient outcomes, and broaden the spectrum of treatable tumors. A bone tumor ablation system is a specialized device designed for minimally invasive treatment of bone tumors. For instance, in March 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool 2 bone tumor ablation system. The upgraded system is intended for treating painful bone metastases and benign bone tumors, including osteoid osteoma. OsteoCool 2 allows simultaneous use of four internally cooled probes, enabling ablation of two vertebral bodies at once or creating larger ablation zones in extra-spinal applications. The system delivers 20W per channel, more than double the power of the Stryker OptaBlate bone tumor ablation system.
In August 2025, K5 Global, a US-based growth-focused technology investment firm, acquired HistoSonics Inc. for $2.25 billion. Through this acquisition, K5 Global aims to accelerate the global commercialization of HistoSonics’ non-invasive tumor-ablation platform and expand its clinical and regulatory presence. HistoSonics is a US-based healthcare technology company that develops the Edison histotripsy system, a focused-ultrasound solution for non-invasive soft-tissue tumor ablation.
Major companies operating in the tumor ablation market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Accuray Incorporated, AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd., Hologic Inc., Johnson & Johnson MedTech.
North America was the largest region in the tumor ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tumor ablation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tumor ablation market by increasing costs of imported ablation probes, generators, imaging guidance systems, and precision electronic components. Oncology centers in North America and Europe are most affected due to reliance on imported high-end medical devices, while Asia-Pacific faces cost pressures on export-oriented manufacturing. These tariffs are increasing procedural equipment costs and slowing technology adoption. However, they are also encouraging domestic device production, localized component sourcing, and innovation in cost-efficient ablation systems.
The tumor ablation market research report is one of a series of new reports that provides tumor ablation market statistics, including tumor ablation industry global market size, regional shares, competitors with a tumor ablation market share, detailed tumor ablation market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation industry. This tumor ablation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Tumor ablation is a minimally invasive medical procedure designed to eliminate cancerous tissues by applying extreme heat, cold, or chemical agents directly to the tumor, causing cell death. This approach is commonly used for treating small tumors or those located in challenging anatomical locations.
The primary types of tumor ablation include thermal ablation and chemical ablation. Thermal ablation involves using extreme heat to destroy abnormal or diseased tissue, and it is employed across various treatments such as percutaneous, laparoscopic, and surgical procedures for conditions such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, among others. End users of these techniques include hospitals, oncology centers, and other healthcare facilities.
The tumor ablation market includes revenues earned by entities by providing services such as consultation, diagnosis, chemical ablation, and post-procedure care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Tumor Ablation Market Characteristics
3. Tumor Ablation Market Supply Chain Analysis
4. Global Tumor Ablation Market Trends and Strategies
5. Tumor Ablation Market Analysis of End Use Industries
7. Global Tumor Ablation Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Tumor Ablation Total Addressable Market (TAM) Analysis for the Market
9. Tumor Ablation Market Segmentation
10. Tumor Ablation Market Regional and Country Analysis
11. Asia-Pacific Tumor Ablation Market
12. China Tumor Ablation Market
13. India Tumor Ablation Market
14. Japan Tumor Ablation Market
15. Australia Tumor Ablation Market
16. Indonesia Tumor Ablation Market
17. South Korea Tumor Ablation Market
18. Taiwan Tumor Ablation Market
19. South East Asia Tumor Ablation Market
20. Western Europe Tumor Ablation Market
21. UK Tumor Ablation Market
22. Germany Tumor Ablation Market
23. France Tumor Ablation Market
24. Italy Tumor Ablation Market
25. Spain Tumor Ablation Market
26. Eastern Europe Tumor Ablation Market
27. Russia Tumor Ablation Market
28. North America Tumor Ablation Market
29. USA Tumor Ablation Market
30. Canada Tumor Ablation Market
31. South America Tumor Ablation Market
32. Brazil Tumor Ablation Market
33. Middle East Tumor Ablation Market
34. Africa Tumor Ablation Market
36. Tumor Ablation Market Competitive Landscape and Company Profiles
37. Tumor Ablation Market Other Major and Innovative Companies
40. Tumor Ablation Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Tumor Ablation Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses tumor ablation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tumor ablation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tumor ablation market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Thermal Ablation; Chemical Ablation2) By Types Of Treatment: Percutaneous; Laparoscopic; Surgical
3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Cancer
4) By End Users: Hospitals; Oncology Centers; Other End Users
Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA); Microwave Ablation (MWA); Cryoablation; Laser Ablation; High-Intensity Focused Ultrasound (HIFU)2) By Chemical Ablation: Ethanol Ablation; Acetic Acid Ablation; Transarterial Chemoembolization
Companies Mentioned: Medtronic plc; Siemens Healthineers AG; Boston Scientific Corporation; Olympus Corporation; Terumo Corporation; Varian Medical Systems Inc.; Merit Medical Systems Inc.; Accuray Incorporated; AngioDynamics Inc.; EDAP TMS S.A.; NeuWave Medical Inc.; Mirabilis Medical Inc.; STARMed Co. Ltd.; Profound Medical Corp.; RF Medical Co. Ltd.; IceCure Medical Ltd.; MedWaves Inc.; Chongqing Haifu Medical Technology Co. Ltd.; Hologic Inc.; Johnson & Johnson MedTech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Tumor Ablation market report include:- Medtronic plc
- Siemens Healthineers AG
- Boston Scientific Corporation
- Olympus Corporation
- Terumo Corporation
- Varian Medical Systems Inc.
- Merit Medical Systems Inc.
- Accuray Incorporated
- AngioDynamics Inc.
- EDAP TMS S.A.
- NeuWave Medical Inc.
- Mirabilis Medical Inc.
- STARMed Co. Ltd.
- Profound Medical Corp.
- RF Medical Co. Ltd.
- IceCure Medical Ltd.
- MedWaves Inc.
- Chongqing Haifu Medical Technology Co. Ltd.
- Hologic Inc.
- Johnson & Johnson MedTech
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.81 Billion |
| Forecasted Market Value ( USD | $ 2.69 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
